Bioactive Toxin-Derived Peptides Antimicrobial & Antimycotic Peptides Custom Research Peptides Nuclear Localization Signals (NLS) Cell-Penetrating Peptides (CPPs) Alzheimer's & Parkinson's Therapeutic Development Melanogenesis Modulation Anti-Aging & Skin Remodeling Ligand-Directed Targeting Peptides Somatostatin Analogs Kinase Activity Modulators Apoptotic Enzymes Viral Protease Substrates Antiviral Peptides Antimicrobial Peptides Cardiovascular Peptides Immunomodulatory Peptides Thyroid Hormone-Related Insulin/Metabolic Regulation Parathyroid Hormone (PTH) Growth Hormone GnRH Analogues/Antagonists Pain and Inflammation Modulation Pituitary Hormones Neurotransmitters/Neuropeptides Standard Fmoc-Amino Acids D-Form Amino Acids Resins Condensation Agents Organic Building Blocks Pseudoproline Dipeptides Phenylalanine & Tryptophan Unusual Amino Acids & Analogs Newly Launched Small-Molecule Specialties Impurity Analysis & Bioactivity Research Special Offers Peptide Synthesis Chemical Synthesis ADMET Profiling Service AlanMolecularAI AlanDockAI Linear Peptide Optimization Cyclic Peptide Optimization Task Management Knowledge Center News About Us Reagents & Custom Orders Aipower Platform
Sign in
Cart
Search
Home Product Peptide Catalog Products Immunomodulatory Peptides Interleukin-6 Receptor (partial)

DESCRIPTION

Interleukin-6 Receptor (partial) is a fragment of the cell surface glycoprotein IL-6R, which mediates signaling by the cytokine interleukin-6 (IL-6). Typically encompassing the extracellular ligand-binding domain (e.g., the Sushi domain and cytokine receptor homology module), this partial receptor retains the ability to interact with IL-6 and initiate downstream signaling through association with the common signal transducer gp130. In physiological contexts, IL-6R signaling drives immune responses, inflammation, hematopoiesis, and cell proliferation, while dysregulation is linked to autoimmune diseases, cancer, and metabolic disorders. In pharmacological research, the partial receptor serves as a tool to investigate ligand-receptor interactions, receptor dimerization mechanisms, and the development of antagonists (e.g., tocilizumab, an anti-IL-6R antibody used in rheumatoid arthritis). Its use facilitates studies on JAK-STAT and MAPK pathway activation, structure-activity relationships, and therapeutic strategies targeting IL-6-mediated inflammatory or proliferative diseases.

Chemical Formula: C51H85N13O21

Molecular Weight: 1216.32

Sequence: Thr-Ser-Leu-Pro-Val-Gln-Asp-Ser-Ser-Ser-Val-Pro

Purity: From crude to 98%

If there are no products available iwth the required purity and quantity, please inform us of your specifications and send an email to sales@alanscientific.com

Our representitives will respond within 24 hours

Research Use Only

Interleukin-6 Receptor (partial)

Catalog No: AS2696

{{ getShowPrice() }} {{ getPrice() }}

Add to Cart Bulk Inquiry
{{ isCollect ? 'Cancel collection' : 'Collection' }}

Related Products

Submit